Phase II Trial of Sorafenib Plus Interferon Alfa-2b As First- or Second-Line Therapy in Patients With Metastatic Renal Cell Cancer
GOLLOB, Jared A, KIMRYN RATHMELL, W, RICHMOND, Tina M, MARINO, Christine B, MILLER, Elizabeth K, GRIGSON, Gayle, WATKINS, Catharine, LIN GU, PETERSON, Bercedis L, WRIGHT, John J
Published in Journal of clinical oncology (01.08.2007)
Published in Journal of clinical oncology (01.08.2007)
Get full text
Journal Article
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancer
Whang, Young E., M.D., Ph.D, Armstrong, Andrew J., M.D, Rathmell, W. Kimryn, M.D., Ph.D, Godley, Paul A., M.D., Ph.D, Kim, William Y., M.D, Pruthi, Raj S., M.D, Wallen, Eric M., M.D, Crane, Jeffrey M., M.D, Moore, Dominic T., M.P.H, Grigson, Gayle, R.N, Morris, Karla, R.N, Watkins, Catharine P., B.A, George, Daniel J., M.D
Published in Urologic oncology (2013)
Published in Urologic oncology (2013)
Get full text
Journal Article
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: A phase II trial
Kim, William Y., M.D, Whang, Young E., M.D., Ph.D, Pruthi, Raj S., M.D, Baggstrom, Maria Q., M.D, Rathmell, W. Kimryn, M.D, Rosenman, Julian G., M.D, Wallen, Eric M., M.D, Goyal, Lav K., M.D, Grigson, Gayle, R.N, Watkins, Catharine, B.A, Godley, Paul A., M.D., Ph.D
Published in Urologic oncology (01.11.2011)
Published in Urologic oncology (01.11.2011)
Get full text
Journal Article